|
|
Volumn 9, Issue 8, 1999, Pages 1101-1118
|
|
PDE4 inhibitors 1999
a
a
NONE
(United Kingdom)
|
|
Author keywords
Asthma; Chronic obstructive pulmonary disease; Phosphodiesterase Type 4 inhibitor; Rheumatoid arthritis; Tumour necrosis factor
|
|
Indexed keywords
4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE;
4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE;
AROFYLLINE;
BENZODIAZEPINE DERIVATIVE;
BENZOFURAN DERIVATIVE;
CATECHOL DERIVATIVE;
CDC 801;
CI 1018;
CIFAMPYLLINE;
CILOMILAST;
D 4418;
INDAZOLE DERIVATIVE;
LIGNAN DERIVATIVE;
PD 168787;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHODIESTERASE IV;
PICLAMILAST;
PTERIDINE DERIVATIVE;
PURINE DERIVATIVE;
QUINOLONE DERIVATIVE;
ROFLUMILAST;
ROLIPRAM;
SH 636;
THALIDOMIDE DERIVATIVE;
THIOPHENE DERIVATIVE;
TOLAFENTRINE DERIVATIVE;
TRIAZINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
XANTHINE DERIVATIVE;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CROHN DISEASE;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG POTENCY;
HUMAN;
MULTIPLE SCLEROSIS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PATENT;
REVIEW;
SKIN DISEASE;
VOMITING;
|
|
EID: 0032779526
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.9.8.1101 Document Type: Review |
|
Times cited : (20)
|
|
References (167)
|
